Delivery Order SPE2DE21D0005-SPE2D626F679A
Award Date 12/2/25
Potential Completion Date 12/5/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, received a delivery order for APLIGRAF from the Defense Logistics Agency (DLA) Medical Supply Chain on October 15, 2025. This fixed-price contract with economic price adjustment carries a ceiling value of $2,479.90 and is scheduled for completion by October 20, 2025. The award was made without any set-aside designation, indicating Organogenesis competed as a standard commercial vendor. APLIGRAF is an advanced...
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain on May 6, 2025, for APLIGRAF products with a ceiling value of $1,239.95. This fixed-price delivery order with economic price adjustment pricing carries an ultimate completion date of May 9, 2025. The award utilizes no set-aside designation, indicating competition on a standard commercial basis. APLIGRAF is an advanced wound...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $2,479.90 by the Defense Logistics Agency (DLA) on November 13, 2025, for the supply of APLIGRAF, an advanced wound care and tissue regeneration product. The contract is a fixed-price delivery with economic price adjustment provisions and carries an ultimate completion date of November 18, 2025. This award represents a single delivery order executed without set-aside...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $1,239.95 for APLIGRAF, an advanced wound care and tissue regeneration product. The contract was issued on October 14, 2025, with an ultimate completion date of October 17, 2025, and carries fixed-price pricing with economic price adjustment terms. No set-aside designation was utilized for this award. The contract is funded through the Defense Logistics Agency's...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $1,239.95 for APLIGRAF, an advanced wound care and tissue regeneration product. The contract, awarded on May 30, 2025, with an ultimate completion date of June 4, 2025, utilizes fixed-price pricing with economic price adjustment terms. The award was made without a set-aside designation, indicating that Organogenesis competed as a standard commercial vendor. The...
- Organogenesis Inc. has been awarded a delivery order valued at $1,239.95 for APLIGRAF, a regenerative medicine product, with an ultimate completion date of October 31, 2025. This fixed-price delivery order with economic price adjustment was issued on October 28, 2025, by the Defense Logistics Agency's Medical Supply Chain division to support federal healthcare operations. The work will be performed at Organogenesis's facility in Canton, Massachusetts. No set-aside designation was utilized for...
- Organogenesis Inc., a Canton, Massachusetts-based regenerative medicine company, received a delivery order award valued at $1,239.95 from the Defense Logistics Agency's Medical Supply Chain for APLIGRAF, an advanced wound care and tissue regeneration product. The contract, awarded on May 7, 2025, carries a fixed price structure with economic price adjustment provisions and is scheduled for completion by May 12, 2025. No set-aside designation was used in this award, indicating Organogenesis...
- Organogenesis Inc. was awarded a delivery order valued at $2,479.90 by the Defense Logistics Agency's Medical Supply Chain division on September 29, 2025, for the supply of APLIGRAF, an advanced wound care and tissue regeneration product. The contract, which carries no set-aside designation, is fixed-price with economic price adjustment provisions and is scheduled for completion by October 2, 2025. Performance will take place at Organogenesis's headquarters in Canton, Massachusetts. This...
- On May 12, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,239.95 to Organogenesis Inc. for APLIGRAF, an advanced regenerative medicine product used in wound care and tissue regeneration. The contract is classified as fixed price with economic price adjustment and carries an ultimate completion date of May 15, 2025. This delivery order was issued without set-aside designation, reflecting Organogenesis's status as a standard commercial vendor...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $1,239.95 by the Defense Logistics Agency's Medical Supply Chain division on October 28, 2025, with an ultimate completion date of October 31, 2025. The award covers APLIGRAF, an advanced skin substitute product used for wound care and tissue regeneration. This delivery order was issued under a fixed-price contract with economic price adjustment terms and did not...